110353 May 2026

: Contraindicated for patients with acute or severe bronchial asthma or significant respiratory depression.

: A thorough assessment of the risk for opioid addiction, abuse, or misuse must be conducted prior to starting therapy. 110353

: Acts directly on the cough center in the brain to suppress the cough reflex. Key Assessment & Safety Monitoring : Contraindicated for patients with acute or severe

-receptor sites. It does not bind to or inactivate histamine itself but prevents it from causing allergic responses. Key Assessment & Safety Monitoring -receptor sites

: Because opioids can cause significant constipation, bowel function should be routinely monitored. Patients are often encouraged to increase fluid and fiber intake or use stimulant laxatives if treatment exceeds 2–3 days. Contraindications and Risks

: It is strictly contraindicated in children under 12 years of age and in children under 18 following surgeries like tonsillectomies due to the risk of fatal respiratory depression.

: Allergy, cold, and cough remedy; antitussive.